ライフサイエンスコーパス: medical research

1 -throughput technologies have revolutionized medical research.

2 erged as a versatile tool for biological and medical research.

3 important issue in the food industry and for medical research.

4 omplex indel discovery and interpretation in medical research.

5 s are invaluable resources for translational medical research.

6 his type of tissue a potential gold mine for medical research.

7 tional antibiotics is a crucial challenge of medical research.

8 ce and Higher Education, Swedish Society for Medical Research.

9 is important for progress in biological and medical research.

10 trated in daily life will also revolutionize medical research.

11 he new technology is applicable in plant and medical research.

12 sity of Minnesota and the Indian Council for Medical Research.

13 r complex systems relevant to biological and medical research.

14 : to act as models for surgical training and medical research.

15 cells with a promising application value in medical research.

16 issues are important resources for molecular medical research.

17 r resulting phenotypes is a crucial task for medical research.

18 e Trust, the Henry Smith Charity, and Action Medical Research.

19 erally, we point to a waste at all stages in medical research.

20 are relevant to fundamental cell biology and medical research.

21 ing, solid state chemistry, biochemistry and medical research.

22 tics in disease has become a central part of medical research.

23 ticipants and unblinded trials are common in medical research.

24 lobally impactful life-saving development of medical research.

25 lthough mouse models are extensively used in medical research.

26 ion of the human genome is indispensable for medical research.

27 rometry has shown to be a valuable method in medical research and can be performed using different in

28 rs significant opportunities in the field of medical research and clinical diagnostics, particularly

29 iction has several potential applications in medical research and clinical practice and could be used

30 at financial conflicts of interest influence medical research and clinical practice.

31 nal roles of HDACs in humans will accelerate medical research and drug discovery in this domain.

32 ease research, but these advances need a new medical research and drug discovery paradigm to gain max

33 lternative tool for biomolecule detection in medical research and early clinical diagnosis.

34 tial alternative tool for miRNA detection in medical research and early clinical diagnosis.

35 NA sequences is significant for both the bio-medical research and the discovery of new drugs.

36 The medical research and training enterprise in the United S

37 h Heart-Lung Foundation, Swedish Society for Medical Research, and Danish Council for Independent Res

38 ols for delivering clinical care, conducting medical research, and enhancing access to infectious dis

39 s, explosive detection at battle fields, bio-medical research, and so on.

40 Drugs and Medical Devices, Japan Agency for Medical Research; and Swiss Cancer Research grant.

41 is this year's recipient of the Lasker Basic Medical Research Award for the identification of the tar

42 This year's Albert Lasker Basic Medical Research Award honors Evelyn Witkin and Stephen

43 year's Lasker approximately Debakey Clinical Medical Research Award honors Ralf Bartenschlager, Charl

44 This year's Lasker Basic Medical Research Award is shared by William Kaelin, Pete

45 r, the Lasker approximately DeBakey Clinical Medical Research Award will be shared by Mahlon R. DeLon

46 This year, the Albert Lasker Basic Medical Research Award will be shared by Peter Walter an

47 ion of this issue is critically important to medical research because the two theories predict that v

48 rstanding among EuroFIR AISBL, Institute for Medical Research, Belgrade, Capacity Development Network

49 cipants from a QIMR (Queensland Institute of Medical Research) Berghofer Medical Research Institute (

50 Warren Medical Research Center for Celiac Disease that addresse

51 dy, a LFI, originally developed by the Naval Medical Research Center for Ebola virus environmental te

52 s of O. tsutsugamushi developed by the Naval Medical Research Center.

53 ent (6-minute-walk distance <350 m, modified Medical Research Council >/=2, chronic bronchitis, St. G

54 Research UK (UK) and the National Health and Medical Research Council (Australia).

55 aland Lottery Board, and National Health and Medical Research Council (Australia).

56 armacology and Therapeutics (funding from UK Medical Research Council (grant number G1000417/94909),

57 and Therapeutics, which is funded by the UK Medical Research Council (grant number G1000417/94909),

58 UK Medical Research Council (grant number MR/J004189/1), Ul

59 ng from the Wellcome Trust (WT088148MF), the Medical Research Council (MR/J008176/1), the NIHR Surgic

60 echanism Evaluation Programme, funded by the Medical Research Council (MRC) and managed by the Nation

61 and Mechanism Evaluation (EME) Programme, a Medical Research Council (MRC) and National Institute fo

62 nherited neuropathy or muscle clinics at the Medical Research Council (MRC) Centre for Neuromuscular

63 Jean study data set (1138 subjects), and the Medical Research Council (MRC) data set (446 subjects).

64 idence interval [CI], 1.01-1.08; P = 0.015), Medical Research Council (MRC) dyspnea grade (OR, 4.57;

65 Limb muscle weakness was defined as a Medical Research Council (MRC) score less than 48.

66 ce of clinically measurable annual change in Medical Research Council (MRC) sum score (-1.5 points pe

67 5c1A seropositive sIBM cases had lower total Medical Research Council (MRC) sum score and MRC sum sco

68 CHDI Foundation Inc.; Medical Research Council (MRC) UK; National Institutes f

69 G) and UK National Cancer Research Institute/Medical Research Council (NCRI/MRC) trials were evaluate

70 Australia's National Health and Medical Research Council (NHMRC) and Victoria's Operatio

71 Australia National Health and Medical Research Council (NHMRC), Health Technologies As

72 Medical Research Council (UK) and National Institute for

73 European Commission, Medical Research Council (UK), and the Wellcome Trust.

74 were baseline measures of dyspnea (modified Medical Research Council [mMRC] scale 0 to 4; 4 represen

75 The Medical Research Council Adjuvant Gastric Infusional Che

76 platin, and fluorouracil chemotherapy in the Medical Research Council Adjuvant Gastric Infusional Che

77 UK Medical Research Council and Economic and Social Researc

78 Medical Research Council and Leukaemia and Lymphoma Rese

79 erman Ministry of Education and Research, UK Medical Research Council and National Institute for Heal

80 d Mechanism Evaluation (EME) programme, a UK Medical Research Council and National Institute for Heal

81 Medical Research Council and National Institute for Heal

82 and Mechanism Evaluation (EME) Programme, a Medical Research Council and National Institute for Heal

83 echanism Evaluation programme, which is a UK Medical Research Council and National Institute of Healt

84 UK Medical Research Council and Public Health England.

85 Medical Research Council and the British Heart Foundatio

86 UK Medical Research Council and the National Institute for

87 Medical Research Council and the Wellcome Trust.

88 Medical Research Council and UK Alzheimer's Society.

89 Medical Research Council and UK National Institute of He

90 esearch UK (C569/A5032), National Health and Medical Research Council Australia (GNT300755, GNT569213

91 Cancer Research UK, National Health and Medical Research Council Australia, Breast Cancer Resear

92 Cancer Research UK, the National Health and Medical Research Council Australia, Sanofi-Aventis, and

93 val of specific frozen brains through the UK Medical Research Council Brain Banks Network.

94 the m.3243A>G mutation were recruited to the Medical Research Council Centre Mitochondrial Disease Pa

95 al Research Centre and is coordinated by the Medical Research Council Clinical Trials Unit (MRC CTU)

96 one by a phone call from the hospital to the Medical Research Council Clinical Trials Unit at Univers

97 Cancer Research UK, Medical Research Council Clinical Trials Unit at Univers

98 ion was done centrally (by telephone) by the Medical Research Council Clinical Trials Unit using mini

99 Randomisation was done by the Medical Research Council Clinical Trials Unit with compu

100 was done by means of a telephone call to the Medical Research Council Clinical Trials Unit, where sta

101 resentative cohort of 28 participants in the Medical Research Council Cognitive Function and Ageing S

102 6-minute-walk distance (6MWD), the Modified Medical Research Council Dyspnea Scale (mMRC), the COPD

103 cough and mild dyspnea on exertion (Modified Medical Research Council dyspnea scale score of 2 [ie, h

104 P < 0.0001) and was also correlated with the Medical Research Council dyspnea score (r = 0.34; P < 0.

105 pitalization were prior hospital admissions, Medical Research Council dyspnea score greater than or e

106 y Questionnaire score, -6.5 points; modified Medical Research Council dyspnea score, -0.6 points; and

107 redicted, and incapacitating breathlessness (Medical Research Council dyspnoea scale >/=4) to receive

108 h worse dyspnoea (adjusted beta for Modified Medical Research Council Dyspnoea Scale 0.12 [95% CI 0.0

109 and a score of 2 or greater on the modified Medical Research Council dyspnoea scale.

110 Questionnaire score was 0.81 (SD 0.78), mean Medical Research Council dyspnoea score was 1.33 (SD 0.6

111 UK Medical Research Council Epidemiology Unit and European

112 EU FP6 programme, Medical Research Council Epidemiology Unit, Medical Rese

113 North West England Medical Research Council Fellowship Scheme in Clinical P

114 g Fellow supported by the North West England Medical Research Council Fellowship Scheme in Clinical P

115 otypes, including dyspnea severity (Modified Medical Research Council grade 0-4), health-related qual

116 , we evaluated spirometry, dyspnea (modified Medical Research Council grade, >/=2), poor respiratory

117 eakness involving the upper and lower limbs (medical research council graded muscle strength as 4+ ou

118 This work was supported by a UK Medical Research Council grant awarded to SSK.

119 idence Database, and the National Health and Medical Research Council Hierarchy of Evidence guide.

120 Medical Research Council Epidemiology Unit, Medical Research Council Human Nutrition Research, and C

121 College London, and the National Health and Medical Research Council in Australia.

122 Cyrus Chothia, an emeritus scientist at the Medical Research Council Laboratory of Molecular Biology

123 d in 397 patients treated intensively in the Medical Research Council Myeloma IX study.

124 lung function prospectively collected by the Medical Research Council National Survey of Health and D

125 ts with 273,843 BMI observations in the 1946 Medical Research Council National Survey of Health and D

126 years in 1,162 British participants from the Medical Research Council National Survey of Health and D

127 d 15 years; 53% boys [n = 1660]) in the 1946 Medical Research Council National Survey of Health and D

128 The Medical Research Council National Survey of Health and D

129 National Health and Medical Research Council of Australia, Richard Pearce Be

130 al Institutes of Health, National Health and Medical Research Council of Australia, Swedish Cancer So

131 an Research Council, and National Health and Medical Research Council of Australia.

132 National Health and Medical Research Council of Australia.

133 National Health and Medical Research Council of Australia.

134 EB is supported by the National Health and Medical Research Council of Australia.

135 lents in University (NCET-11-0529), National Medical Research Council of Singapore (TCR12DEC005), Tan

136 Executive, Irish National Lottery, National Medical Research Council of Singapore, Swiss National Sc

137 Wellcome Trust (UK), Medical Research Council of South Africa, Human Science

138 f an inconclusive 1927 report by the British Medical Research Council on the hereditary versus social

139 BD held an Medical Research Council Population Health Scientist Fel

140 NCIC Clinical Trials Group PR.3/Medical Research Council PR07/Intergroup T94-0110 was a

141 Urine samples obtained during the Medical Research Council PRION-1 Trial, the National Pri

142 y, codon 129 methionine valine polymorphism, Medical Research Council Rating Scale score, and histopa

143 mptoms (chronic bronchitis, dyspnea-modified Medical Research Council scale and baseline dyspnea inde

144 abel randomized trial using 50% reduction in Medical Research Council Scale decline as the primary ou

145 Interrater reliability of the Medical Research Council scale for individual muscle gro

146 with faster disease progression (upper-limb Medical Research Council scale progression rate, r = 0.4

147 functionally orientated composite end point (Medical Research Council Scale) and associated with clin

148 287), and dyspnea was defined as a modified Medical Research Council score >/=1 (n = 18).

149 espiratory Questionnaire score, and modified Medical Research Council score were assessed at 3 and 6

150 standardized manual muscle testing using the Medical Research Council sum score (range, 0-60; higher

151 inical outcome: muscle weakness (measured by Medical Research Council sum score), respiratory failure

152 mong patients without ICU-acquired weakness (Medical Research Council sum score, >/= 48 vs < 48) and

153 001), and severe muscle weakness at 4 weeks (Medical Research Council sum score, 31.8 vs 52.9, P < .0

154 score, 31.8 vs 52.9, P < .001) and 6 months (Medical Research Council sum score, 49.4 vs 58.4, P < .0

155 y for Education and Research (BmBF), and the Medical Research Council UK (MRC).

156 ouncil of Australia, Swedish Cancer Society, Medical Research Council UK, Cambridge NIHR Biomedical R

157 Wellcome Trust, Medical Research Council UK, Department for Internationa

158 luded 3,113 patients who were treated in the Medical Research Council UKALL2003 multicenter randomize

159 South African Medical Research Council's Flagships Awards Project.

160 uenay-Lac-Saint-Jean) families and 207 MRCA (Medical Research Council) families.

161 oek-Vlaanderen, Parents Organization, Danish Medical Research Council, Academy of Finland, Deutsche F

162 British Heart Foundation, UK Medical Research Council, and Academy of Finland.

163 ry of Health, Australian National Health and Medical Research Council, and Asia Pacific Malaria Elimi

164 newells Cancer Campaign, National Health and Medical Research Council, and German Federal Ministry of

165 isease Control and Prevention, South African Medical Research Council, and MAC AIDS Fund.

166 Wellcome Trust, Medical Research Council, and National Institutes of Hea

167 the UK National Cancer Research Network, the Medical Research Council, and Roche.

168 rust, National Institute of Health Research, Medical Research Council, and the European Union.

169 ational Institute of Health Research (NIHR), Medical Research Council, and the NIHR Oxford Biomedical

170 ust, National Institute for Health Research, Medical Research Council, and the NIHR Oxford Biomedical

171 come Trust, Bill & Melinda Gates Foundation, Medical Research Council, and UK Department for Internat

172 Wellcome Trust, Medical Research Council, and UK National Institute for

173 Fellowship), Australian National Health and Medical Research Council, and US National Institutes of

174 Primary Funding Sources: National Health and Medical Research Council, Australia and BUPA Health Foun

175 National Health and Medical Research Council, Australia.

176 Medical Research Council, Bill & Melinda Gates Foundatio

177 Medical Research Council, Bill & Melinda Gates Foundatio

178 UK Medical Research Council, Biotechnology and Biological S

179 Cambridge NIHR Biomedical Research Centre, Medical Research Council, British Heart Foundation, Assi

180 UK Medical Research Council, British Heart Foundation, Canc

181 UK Medical Research Council, British Heart Foundation, Univ

182 UK Medical Research Council, British Heart Foundation.

183 Arthritis Research UK, Medical Research Council, Bupa Foundation, and National

184 British Heart Foundation, Medical Research Council, Cambridge National Institute f

185 h Foundation, Australian National Health and Medical Research Council, Cancer Australia, Sarcoma UK,

186 Medical Research Council, Cancer Research UK, Canadian C

187 Medical Research Council, Cancer Research UK, Department

188 Past funding was received from the Medical Research Council, Cancer Research UK, the UK Dep

189 UK Medical Research Council, Cancer Research UK.

190 US National Institutes of Health, UK Medical Research Council, Cancer Research UK.

191 UK Medical Research Council, Chief Scientist Office of the

192 North Rhine-Westphalia, Cancer Research UK, Medical Research Council, Commonwealth Fund.

193 les (France), Australian National Health and Medical Research Council, Danish National Research Found

194 UK Medical Research Council, Department of Health for Engla

195 UK Medical Research Council, Department of Health for Engla

196 Wellcome Trust, Medical Research Council, Economic and Social Research C

197 Medical Research Council, Economic and Social Research C

198 Medical Research Council, European Union New and Emergin

199 Wellcome Trust, UK Medical Research Council, European Union, and Foundation

200 Heart and Stroke Scotland, UK Medical Research Council, Health Foundation UK, Stroke A

201 Wellcome Trust, UK Medical Research Council, Li Ka Shing Foundation.

202 UK Medical Research Council, National Cancer Institute, Eur

203 Medical Research Council, National Institute for Health

204 on Drug Abuse, Australian National Health & Medical Research Council, National Institute of Mental H

205 neas Trust, the Baily Thomas Foundation, the Medical Research Council, NIHR-CLAHRC-EoE, Cambridgeshir

206 UK Medical Research Council, Norwegian Agency for Developme

207 ship in Applied Health Research and Care, UK Medical Research Council, Nottinghamshire Healthcare NHS

208 Cancer Research UK, Medical Research Council, Novartis, Sanofi-Aventis, Pfiz

209 ety, Cancer Research UK, National Health and Medical Research Council, Project Grant, Cancer Australi

210 K National Institute for Health Research, UK Medical Research Council, Public Health England, and Dep

211 , UK National Institute for Health Research, Medical Research Council, Public Health England.

212 National Institute for Health Research, Medical Research Council, Sands, and GE Healthcare.

213 South African Medical Research Council, Sigrid Rausing Trust, WHO.

214 Wellcome Trust, Wolfson Foundation, UK Medical Research Council, Stroke Association, British He

215 Medical Research Council, Stroke Association, Sanofi-Syn

216 or Malaria Venture (Geneva, Switzerland), UK Medical Research Council, Swedish International Developm

217 t Foundation, Australian National Health and Medical Research Council, Swiss National Research Founda

218 Australian National Health and Medical Research Council, the Women's and Children's Hos

219 oundation, National Institutes of Health, UK Medical Research Council, UK Department for Internationa

220 UK Medical Research Council, UK Department for Internationa

221 UK Medical Research Council, UK Department for Internationa

222 Medical Research Council, UK Department for Internationa

223 UK Medical Research Council, UK Wellcome Trust, Parkinson's

224 ouwer and WT081794, to J.N. Jarvis), and the Medical Research Council, United Kingdom (76201).

225 es of Health, Australian National Health and Medical Research Council, US National Cancer Institute,

226 UK Medical Research Council, Wellcome Trust, Biotechnology

227 Medical Research Council, Wellcome Trust, Economic and S

228 r Research UK, Yorkshire Cancer Research, UK Medical Research Council, Wellcome Trust, EU Framework C

229 UK, National Institute for Health Research, Medical Research Council, Wellcome Trust, The Scottish G

230 US National Institutes of Health, UK Medical Research Council, Wellcome Trust.

231 r Medical Sciences-TT2 (UAMS-TT2), UAMS-TT3, Medical Research Council-IX, Assessment of Proteasome In

232 Interrater reliability of the Medical Research Council-sum score was found to be very

233 oundation and Australian National Health and Medical Research Council.

234 h Research, British Heart Foundation, and UK Medical Research Council.

235 ates Foundation, Grand Challenges Canada, UK Medical Research Council.

236 GlaxoSmithKline R&D and the Medical Research Council.

237 Australian National Health and Medical Research Council.

238 terloo Foundation, Autism Speaks, and the UK Medical Research Council.

239 National Institute for Health Research, and Medical Research Council.

240 National Institute for Health Research, UK Medical Research Council.

241 es of Health; Australian National Health and Medical Research Council.

242 The Bill & Melinda Gates Foundation and Medical Research Council.

243 litis Australia, and the National Health and Medical Research Council.

244 , National Institute for Health Research, UK Medical Research Council.

245 Australian National Health & Medical Research Council.

246 ank Group and Australian National Health and Medical Research Council.

247 US National Institutes of Health, UK Medical Research Council.

248 Australian National Health and Medical Research Council.

249 ute for Health Research, Wellcome Trust, and Medical Research Council.

250 Moulton Charitable Foundation and Medical Research Council.

251 Australian Government National Health and Medical Research Council.

252 Australia's National Health and Medical Research Council.

253 h Foundation (SARChI), and the South African Medical Research Council.

254 nfectious Diseases, Merck, and South African Medical Research Council.

255 es of Health, Australian National Health and Medical Research Council.

256 Bill & Melinda Gates Foundation, UK Medical Research Council.

257 s, the European Union, and the South African Medical Research Council.

258 Bill & Melinda Gates Foundation, and the UK Medical Research Council.

259 Australian National Health and Medical Research Council.

260 Medical Research Council/National Institute for Health R

261 line group of companies), Wellcome Trust UK, Medical Research Council: Respiratory and Meningeal Path

262 Australian National Health and Medical Research Council; Children's Health Foundation Q

263 Melinda Gates Foundation; Global Good Fund; Medical Research Council; UK Department for Internationa

264 d Publication Practice for Company-Sponsored Medical Research, Data Sharing, Studies That Should Be P

265 dividuals from the same species, most of the medical research deals with the variants in the sequence

266 Canterbury Medical Research Foundation, Italian Medicines Agency.

267 and a commissioned grant from the Health and Medical Research Fund from the Government of the Hong Ko

268 ommunicable Disease Dynamics, and Health and Medical Research Fund, Government of Hong Kong Special A

269 Thomas' Charity, Dystonia Society UK, Action Medical Research, German National Academic Foundation.

270 This new trend in medical research has been termed "predictive medicine."

271 Medical research has evolved conventions for choosing sa

272 uate school at The Rockefeller Institute for Medical Research in New York City in July 1965.

273 complement traditional clinical outcomes in medical research, including in multiple sclerosis (MS).

274 atus in September 2010 was obtained from the Medical Research Information Service.

275 the French National Institute of Health and Medical Research, INSERM]).

276 pipelines designed by the United States Army Medical Research Insititute of Infectious Diseases and W

277 ial at the clinical trial sites of the Kenya Medical Research Institute (KEMRI)-Walter Reed Army Inst

278 and Institute of Medical Research) Berghofer Medical Research Institute (QIMR) cohort.

279 iosafety level 4 laboratories at the US Army Medical Research Institute of Infectious Diseases in the

280 s been a notable failure of translation from medical research into clinical practice.

281 Medical research is a prerequisite of clinical advances,

282 However, their use in medical research is hampered by laborious reprogramming

283 Medical research is moving toward prevention strategies

284 z Burchard and colleagues explore how making medical research more diverse would aid not only social

285 ence, when national data suggest that future medical research needs in a scientific area may be met i

286 RNA databases, diminishing the usefulness of medical research on spontaneous disease in cats for appl

287 hat may improve the quality of peer-reviewed medical research publications.

288 Foundation Queensland; Office of Health and Medical Research, Queensland Health; European Respirator

289 e government is distributing their taxes for medical research, relative to their health needs.

290 h, Semmelweis Foundation, ZonMw (Council for Medical Research), Research Council of Norway, Scandinav

291 sk Foundation, National Institutes of Health Medical Research Scholars Program, and Pharmacyclics Inc

292 h Heart-Lung Foundation, Swedish Society for Medical Research, Strategic Research Program in Epidemio

293 Many cell lines currently used in medical research, such as cancer cells or stem cells, gr

294 Foundation, Swisslife Jubilaumsstiftung for Medical Research, Swiss Neurological Society, Fondazione

295 , which has been extensively investigated in medical research, the neutral species of amine-containin

296 Within medical research there is an increasing trend toward der

297 o Schedule 2, should be implemented to allow medical research to develop appropriately.

298 Peel Medical Research Trust, Alliance Family Foundation, Acti

299 ltiple perspectives and draws on more recent medical research, while acknowledging that the available

300 ustering approaches outside the scope of bio-medical research, with the additional ability to integra